Cleveland BioLabs, Inc. Soared
Fri, Sep 11, 2020 at 05:30 PM
Cleveland BioLabs, Inc. (CBLI:NASDAQ) shot up at $2.32, a gain of 22.8%. On Thu 10 Sep 20, CBLI:NASDAQ touched a New 2-Week Intraday High of $1.98. From Thu 27 Aug 20, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Fri 26 Jun 20 at $4.43 with a volume of 51M+, and its share price has been moving sideways in recent weeks.
About Cleveland BioLabs, Inc. (CBLI:NASDAQ)
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.
Top 10 Gainers:
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 37.51%
- Salem Media Group, Inc. (SALM:NASDAQ), 35.57%
- NNOX (NNOX:NASDAQ), 32.87%
- LTRN (LTRN:NASDAQ), 27.84%
- A-Mark Precious Metals, Inc. (AMRK:NASDAQ), 27.21%
- Cinedigm Corp. (CIDM:NASDAQ), 27.09%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 22.75%
- Natural Health Trends Corp. (NHTC:NASDAQ), 21.6%
- Biofrontera AG (BFRA:NASDAQ), 18.97%
- Teligent, Inc. (TLGT:NASDAQ), 18.8%